The multiple roles of epidermal growth factor repeatO-glycans in animal development
Open Access
- 14 July 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 25 (10), 1027-1042
- https://doi.org/10.1093/glycob/cwv052
Abstract
The epidermal growth factor (EGF)-like repeat is a common, evolutionarily conserved motif found in secreted proteins and the extracellular domain of transmembrane proteins. EGF repeats harbor six cysteine residues which form three disulfide bonds and help generate the three-dimensional structure of the EGF repeat. A subset of EGF repeats harbor consensus sequences for the addition of one or more specific O-glycans, which are initiated by O-glucose, O-fucose or O-N-acetylglucosamine. These glycans are relatively rare compared to mucin-type O-glycans. However, genetic experiments in model organisms and cell-based assays indicate that at least some of the glycosyltransferases involved in the addition of O-glycans to EGF repeats play important roles in animal development. These studies, combined with state-of-the-art biochemical and structural biology experiments have started to provide an in-depth picture of how these glycans regulate the function of the proteins to which they are linked. In this review, we will discuss the biological roles assigned to EGF repeat O-glycans and the corresponding glycosyltransferases. Since Notch receptors are the best studied proteins with biologically-relevant O-glycans on EGF repeats, a significant part of this review is devoted to the role of these glycans in the regulation of the Notch signaling pathway. We also discuss recently identified proteins other than Notch which depend on EGF repeat glycans to function properly. Several glycosyltransferases involved in the addition or elongation of O-glycans on EGF repeats are mutated in human diseases. Therefore, mechanistic understanding of the functional roles of these carbohydrate modifications is of interest from both basic science and translational perspectives.Keywords
Funding Information
- NIH/NIGMS (R01GM084135)
- Mizutani Foundation for Glycoscience (110071)
- March of Dimes Foundation (1-FY10-501)
- Grace Wilsey Foundation
This publication has 146 references indexed in Scilit:
- RBPJ Mutations Identified in Two Families Affected by Adams-Oliver SyndromeAmerican Journal of Human Genetics, 2012
- The double-edged sword of Notch signaling in cancerSeminars in Cell & Developmental Biology, 2012
- Notch signaling in human development and diseaseSeminars in Cell & Developmental Biology, 2012
- Association of common variants in the human eyes shut ortholog (EYS) with statin‐induced myopathy: Evidence for additional functions of EYSMuscle & Nerve, 2011
- Crumbs Regulates Salvador/Warts/Hippo Signaling in Drosophila via the FERM-Domain Protein ExpandedCurrent Biology, 2010
- Manic fringe is not required for embryonic development, and fringe family members do not exhibit redundant functions in the axial skeleton, limb, or hindbrainDevelopmental Dynamics, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Identification of a 2 Mb Human Ortholog of Drosophila eyes shut/spacemaker that Is Mutated in Patients with Retinitis PigmentosaAmerican Journal of Human Genetics, 2008
- O-fucosylation of muscle agrin determines its ability to cluster acetylcholine receptorsMolecular and Cellular Neuroscience, 2008
- Rumi Is a CAP10 Domain Glycosyltransferase that Modifies Notch and Is Required for Notch SignalingCell, 2008